Many opportunities, from many marine secondary metabolites including
some of the most interesting candidate drugs, have to be used for development in
marine drug discovery in parallel to the updated technologies, procedures and
protocols. The hope and the net result, in such a manner, are related to the acceleration
and management of marine drug discovery as an integrated process from obtaining the
sampling until the launch of the drug. The recent protocols targeted gene sequencing
methods for identifying secondary metabolic pathways to be used in the biosynthesis of
marine natural products (MNP) discovered from marine isolates. Afterward, the
synthesis processes for replenishing inventories of compounds and analogs is a critical
step. Moreover, the cheminformatics and computer screening of MNP for protein
targets have been used to some extent. On the other hand, the collaboration allows
sharing of knowledge, tools, finances, and administrative processes, therefore
increasing the innovation potential of all parties, playing a greater role. Seriously, the
future prospects for developing marine drug discovery involve the collection of
relevant information and the evaluation of available opportunities to establish goals
through government initiatives and finally to invest and market the drug products from
marine origin. In the current chapter, the advanced approaches to marine drug
discovery will be explained. Furthermore, this chapter will present both collaboration
and innovation in marine drug discovery to increase the effectiveness of drug discovery
and advance the production process.